Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial.

Kohei ShitaraMaria Di BartolomeoMario MandalaMin-Hee RyuChristian CaglevicTomasz OlesińskiHyun Cheol ChungKei MuroEray GoekkurtRaymond S McDermottWasat MansoorZev A WainbergChie-Schin ShihJulie KobieMichael NebozhynRazvan CristescuZ Alexander CaoAndrey LobodaMustafa Özgüroğlu

Published in: Journal for immunotherapy of cancer (2023)

NCT02370498.

Keyphrases

phase iii
phase ii
open label
gene expression
clinical trial
double blind
placebo controlled
dna methylation
genome wide
neoadjuvant chemotherapy
study protocol
squamous cell carcinoma
tyrosine kinase
rectal cancer
locally advanced